News
UPC
0.5901
+1.44%
0.0084
FedEx: When Size Doesn't Matter
Seeking Alpha · 02/07 23:07
Why Ontrak Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga · 01/18 18:25
DMTK, OTRK and BTB among mid-day movers
Seeking Alpha · 01/18 17:44
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 01/18 17:31
TC Biopharm, G Medical top healthcare gainers; Lucid, Hyperfine among losers
Seeking Alpha · 01/18 15:00
Why KNOT Offshore Partners Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga · 01/12 18:19
APPH, SLRX and ARBK among mid-day movers
Seeking Alpha · 01/12 17:57
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 01/12 17:31
Universe Pharmaceuticals INC Announces Inclusion Of Six Products Into The First Edition Of Catalogue Of Medicine For Patients Infected With COVID-19
Benzinga · 12/21/2022 13:15
Nasdaq notifies Universe Pharmaceuticals on regaining compliance with minimum price requirement
Seekingalpha · 11/14/2022 13:39
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers
Benzinga · 10/11/2022 21:57
Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From Yesterday
Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares climbed 71% to close at $2.12 on Monday after the company announced it has received its largest single purchase order for LinearDNA™ valued above the mid-six-figures.
Benzinga · 10/11/2022 06:17
Why Applied DNA Sciences Shares Are Trading Higher By Around 65%, Here Are 54 Stocks Moving In Monday's Mid-Day Session
Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares jumped 64.5% to $2.03 after the company announced it has received its largest single purchase order for LinearDNA™ valued above the mid-six-figures.
Benzinga · 10/10/2022 15:59
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Benzinga · 09/12/2022 12:29
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Benzinga · 09/06/2022 12:15
Universe Pharmaceuticals GAAP EPS of $0.08, revenue of $24.2M
Universe Pharmaceuticals press release (<span c...
Seekingalpha · 08/16/2022 12:47
Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2022
Universe Pharmaceuticals INC (the "Company") (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced its unaudited financial results for the first six months of fiscal year 2022 ended March 31, 2022.
PR Newswire · 08/16/2022 12:00
Universe pharmaceuticals receives Nasdaq notification regarding minimum bid price deficiency
Universe Pharmaceuticals (NASDAQ:UPC) received Nasdaq <a hre...
Seekingalpha · 07/19/2022 10:11
Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Ji’an, Jiangxi, China, July 19, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company received a written notification (the “Notification Let...
GlobeNewswire · 07/19/2022 10:00
Universe Pharmaceuticals Receives Minimum Bid Price Deficiency Notice From Nasdaq
MT Newswires · 07/19/2022 06:38
More
Webull provides a variety of real-time UPC stock news. You can receive the latest news about Universe Pharmaceuticals Inc through multiple platforms. This information may help you make smarter investment decisions.
About UPC
Universe Pharmaceuticals Inc is a China-based holding company mainly engaged in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (TCMD) products targeting the elderly. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The Company mainly conducts its businesses within the Chinese market.